"MTPA’s Radicava shows long-term benefit in ALS trials" was originally created and published by Clinical Trials Arena, a ...

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease or Lou Gehrig's Disease, ...

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...

The amyotrophic lateral sclerosis (ALS) treatment market was valued at USD 791.90 Million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 5.40% from 2025 to 2034.

Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...

Safety & Health First Responder Class on Amyotrophic Lateral Sclerosis (ALS) This event is designed to help all first responders be better prepared when responding to a call involving someone with ALS ...

BOYNTON BEACH, Fla. — Boynton Beach Mayor Ty Penserga proclaimed Sept. 28 as ALS Awareness Day. Amyotrophic lateral sclerosis is a disease that attacks the nervous system, affecting nerve cells ...

Amyotrophic Lateral Sclerosis Treatment Market Distribution Channel Insights Hospital pharmacies held a significant revenue share in the amyotrophic lateral sclerosis (ALS) treatment market in ...